Johnson & Johnson Faces New Lawsuit(s) Related To Its Talc Products
Johnson & Johnson faces a new class action lawsuit seeking damages and medical monitoring for cancer risk from talc products.
Johnson & Johnson’s Arthritis Drug Shows Potential In Crohn’s Disease
Johnson & Johnson announced that their Phase 3 GRAVITI study of Tremfya (guselkumab) SC therapy for Crohn's disease met all primary and secondary endpoints.
3 Mega Cap Stock Bargains As Markets Hit All-Time Highs
We ran a screener using Benzinga Pro to filter out three mega-cap stocks that are currently trading at attractive valuations.
Legend Biotech’s Cancer Drug, ‘The Most Attractive Product,’ Set For Growth: Analyst
Legend Biotech analyst predicts growth for Carvykti. The Multiple Myeloma drug could become a $5B+ product.
What’s Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for relapsed/refractory B-cell malignancies
Market Analysis: Johnson & Johnson And Competitors In Pharmaceuticals Industry
In today’s fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct…
In-Depth Examination Of 11 Analyst Recommendations For Johnson & Johnson
11 analysts have expressed a variety of opinions on Johnson & Johnson (NYSE:JNJ) over the past quarter, offering…
How Is The Market Feeling About Johnson & Johnson?
Johnson & Johnson’s (NYSE:JNJ) short percent of float has risen 15.28% since its last report. The company recently…
Wall Street’s Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors…
Johnson & Johnson To Pay $700M To Settle Multi-State Talc Investigation
Although the settlement has been reached, Johnson & Johnson still faces a substantial number of talc-related lawsuits.